Jesslin Abraham, M.D.

Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>

29.09.2025 19:03 — 👍 7    🔁 7    💬 0    📌 0

Such a great opportunity, to be involved in an editorial on the most recent evidence for Subclinical Primary Aldosteronism. Thank you to @drwanpen.bsky.social @giaconajohn.bsky.social

Go check it out!! www.ahajournals.org/doi/10.1161/...

29.09.2025 18:52 — 👍 3    🔁 3    💬 0    📌 1

Great dinner celebrating #Hypertension25 together near harbor with UTSW group Angie Price @giaconajohn.bsky.social @robynwei.bsky.social @jesslin23.bsky.social and Mu Huang

06.09.2025 00:43 — 👍 8    🔁 3    💬 0    📌 0

Thank you to AHA for the opportunity to present at AHA HTN scientific session 25 in Baltimore. Having an amazing time meeting and connecting with experts in the field! @drwanpen.bsky.social @giaconajohn.bsky.social
@robynwei.bsky.social

04.09.2025 18:37 — 👍 7    🔁 3    💬 1    📌 0

Great talk #Hypertension25 by @jesslin23.bsky.social in discussing limitations of visual estimation of home BP in clinical decision in Rx HTN in Eyeball study @robynwei.bsky.social @giaconajohn.bsky.social

04.09.2025 15:59 — 👍 7    🔁 4    💬 0    📌 0

Got to Baltimore #Hypertension25 so excited to see friends and colleagues talking about high BP ! @ahascience.bsky.social @giaconajohn.bsky.social

03.09.2025 21:15 — 👍 12    🔁 6    💬 0    📌 0

Another fun Hypertension JC today. Bedmed trial was disccused by Jesslin Abraham our fellow. @giaconajohn.bsky.social @hkkimphd.bsky.social @utswim.bsky.social

11.07.2025 18:10 — 👍 6    🔁 2    💬 0    📌 0

Join us @jordybc.bsky.social , Keith Ferdinand, and Dan Jones unpacking 2025 AHA/ACC guidelines on Thursday Aug 28 bit.ly/Guideline25W... @UTSWInternalMed @utswheart

19.08.2025 23:39 — 👍 9    🔁 7    💬 0    📌 0